Black Rock Inc. Vaccinex, Inc. Transaction History

Black Rock Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	SELL	$0.34 - $0.48 $16,874 - $23,822	-49,631 Reduced 95.08%	2,566 $0
Q1 2023 May 12, 2023	BUY	$0.39 - $0.65 $627 - $1,045	1,608 Added 3.18%	52,197 $20,000
Q4 2022 Feb 13, 2023	BUY	$0.44 - $0.74 $471 - $793	1,072 Added 2.16%	50,589 $32,000
Q3 2022 Nov 14, 2022	SELL	$0.48 - $1.2 $6,576 - $16,440	-13,700 Reduced 21.67%	49,517 $25,000
Q2 2022 Aug 12, 2022	BUY	$1.05 - $1.39 $16,481 - $21,818	15,697 Added 33.03%	63,217 $68,000

Q1 2022 May 12, 2022	SELL	$0.92 - $1.94 $2,020 - $4,260	-2,196 Reduced 4.42%	47,520 $63,000
Q4 2021 Feb 10, 2022	BUY	$1.04 - $2.12 $1,268 - $2,586	1,220 Added 2.52%	49,716 $52,000
Q3 2021 Nov 09, 2021	SELL	$2.11 - $2.81 $2,059 - $2,742	-976 Reduced 1.97%	48,496 $105,000
Q2 2021 Aug 11, 2021	BUY	$2.01 - $3.0 $99,438 - $148,416	49,472 New	49,472 $139,000

426K

Ticker VCNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,664,100
Market Cap $287M
Description
Vaccinex, Inc., a clinical-stage biotechnology company, engages in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs. The company offers its products for the treatment of cancer, neurodegenerative diseases, and autoimmune disorders. Its lead product candidate is pepinemab,...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.